Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Messerli

Showing results (141-150 of 338) with videos related to

Pageof 34
Sort By:
The American Journal of Medicine|April 27, 1992
Is the decrease in arterial pressure the sole factor for reduction of left ventricular hypertrophy?R E Schmieder, F H Messerli
Lancet (London, England)|October 25, 1980
Potassium chloride and thromboembolic complications: a hypothesisF H Messerli, N D Pappas
European Heart Journal|July 24, 2001
Antihypertensive therapy and the risk of malignanciesE Grossman, F H Messerli, U Goldbourt
The American Journal of Cardiology|November 25, 2000
Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertensionF H Messerli, S Oparil, Z Feng
Current Hypertension Reports|September 12, 2000
Carcinogenicity of cardiovascular drugsE Grossman, F H Messerli, U Goldbourt
The American Journal of Cardiology|April 6, 1999
Does diuretic therapy increase the risk of renal cell carcinoma?E Grossman, F H Messerli, U Goldbourt
Archives of Internal Medicine|July 27, 1999
Antihypertensive therapy in the elderly: evidence-based guidelines and realityF H Messerli, T Grodzicki, Z Feng
American Journal of Hypertension|June 2, 1998
Aging and essential hypertension: effect of left ventricular hypertrophy on cardiac functionT Grodzicki, L Michalewicz, F H Messerli
The American Journal of Cardiology|July 1, 1991
Left ventricular filling in the systemic hypertension of obesityE Grossman, S Oren, F H Messerli
Journal of Human Hypertension|June 1, 1994
Left ventricular mass and cardiac function in patients with essential hypertensionE Grossman, S Oren, F H Messerli
Pageof 34

Showing results (141-150 of 338) with videos related to

Sort By:
Pageof 34
The American Journal of Medicine|April 27, 1992
Is the decrease in arterial pressure the sole factor for reduction of left ventricular hypertrophy?R E Schmieder, F H Messerli
Lancet (London, England)|October 25, 1980
Potassium chloride and thromboembolic complications: a hypothesisF H Messerli, N D Pappas
European Heart Journal|July 24, 2001
Antihypertensive therapy and the risk of malignanciesE Grossman, F H Messerli, U Goldbourt
The American Journal of Cardiology|November 25, 2000
Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertensionF H Messerli, S Oparil, Z Feng
Current Hypertension Reports|September 12, 2000
Carcinogenicity of cardiovascular drugsE Grossman, F H Messerli, U Goldbourt
The American Journal of Cardiology|April 6, 1999
Does diuretic therapy increase the risk of renal cell carcinoma?E Grossman, F H Messerli, U Goldbourt
Archives of Internal Medicine|July 27, 1999
Antihypertensive therapy in the elderly: evidence-based guidelines and realityF H Messerli, T Grodzicki, Z Feng
American Journal of Hypertension|June 2, 1998
Aging and essential hypertension: effect of left ventricular hypertrophy on cardiac functionT Grodzicki, L Michalewicz, F H Messerli
The American Journal of Cardiology|July 1, 1991
Left ventricular filling in the systemic hypertension of obesityE Grossman, S Oren, F H Messerli
Journal of Human Hypertension|June 1, 1994
Left ventricular mass and cardiac function in patients with essential hypertensionE Grossman, S Oren, F H Messerli
Pageof 34